AEYE (AudioEye, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by AEYE officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-20 | Matthew Domeyer | Chief Financial Officer | A | — | — |
| 2026-07-02 | Kelly Georgevich | CEO, CFO AND SECRETARY | F | — | — |
| 2026-07-02 | JAMES B HAWKINS | Director | A | — | — |
| 2026-07-02 | Katherine E. Fleming | Director | A | — | — |
| 2026-07-02 | Jamil A. Tahir | Director | A | — | — |
| 2026-07-02 | David Moradi | EXECUTIVE CHAIRMAN AND CPO | F | — | — |
| 2026-06-24 | Jamil A. Tahir | Director | A | — | — |
| 2026-06-24 | JAMES B HAWKINS | Director | A | — | — |
| 2026-06-24 | Katherine E. Fleming | Director | A | — | — |
| 2026-05-06 | David Moradi | EXECUTIVE CHAIRMAN AND CPO | MIXED | — | — |
| 2026-05-06 | Kelly Georgevich | CEO, CFO AND SECRETARY | MIXED | — | — |
| 2026-04-03 | Katherine E. Fleming | Director | A | — | — |
| 2026-04-03 | JAMES B HAWKINS | Director | A | — | — |
| 2026-04-03 | Jamil A. Tahir | Director | A | — | — |
| 2026-03-17 | Kelly Georgevich | CHIEF FINANCIAL OFFICER | Buy | — | — |
| 2026-03-12 | JAMES B HAWKINS | Director | Buy | — | — |
| 2026-02-11 | Kelly Georgevich | CHIEF FINANCIAL OFFICER | A | — | — |
| 2026-01-13 | David Moradi | CHIEF EXECUTIVE OFFICER | F | — | — |
| 2026-01-05 | Katherine E. Fleming | Director | A | — | — |
| 2026-01-05 | JAMES B HAWKINS | Director | A | — | — |
| 2026-01-05 | Kelly Georgevich | CHIEF FINANCIAL OFFICER | F | — | — |
| 2026-01-05 | Jamil A. Tahir | Director | A | — | — |
| 2025-11-24 | JAMES B HAWKINS | Director | Buy | — | — |
| 2025-11-19 | JAMES B HAWKINS | Director | Buy | — | — |
| 2025-11-13 | JAMES B HAWKINS | Director | Buy | — | — |
| 2025-11-12 | JAMES B HAWKINS | Director | Buy | — | — |
| 2025-10-03 | Katherine E. Fleming | Director | A | — | — |
| 2025-10-03 | JAMES B HAWKINS | Director | A | — | — |
| 2025-10-03 | Jamil A. Tahir | Director | A | — | — |
| 2025-09-08 | Jamil A. Tahir | Director | Buy | — | — |
| 2025-08-22 | David Moradi | CHIEF EXECUTIVE OFFICER | MIXED | — | — |
| 2025-08-19 | JAMES B HAWKINS | Director | Buy | — | — |
| 2025-07-03 | JAMES B HAWKINS | Director | A | — | — |
| 2025-07-03 | Katherine E. Fleming | Director | A | — | — |
| 2025-07-03 | Jamil A. Tahir | Director | A | — | — |
| 2025-06-24 | Kelly Georgevich | CHIEF FINANCIAL OFFICER | F | — | — |
| 2025-06-24 | JAMES B HAWKINS | Director | X | — | — |
| 2025-06-17 | JAMES B HAWKINS | Director | X | — | — |
| 2025-06-05 | Jamil A. Tahir | Director | A | — | — |
| 2025-06-05 | Katherine E. Fleming | Director | A | — | — |
| 2025-06-05 | JAMES B HAWKINS | Director | A | — | — |
| 2025-05-28 | Katherine E. Fleming | Director | A | — | — |
| 2025-05-28 | JAMES B HAWKINS | Director | A | — | — |
| 2025-05-28 | Jamil A. Tahir | Director | A | — | — |
| 2025-05-02 | Carr Bettis | EXEC CHRMN/CHRMN OF THE BOARD | MIXED | — | — |
| 2025-04-03 | JAMES B HAWKINS | Director | A | — | — |
| 2025-04-03 | Katherine E. Fleming | Director | A | — | — |
| 2025-04-03 | Jamil A. Tahir | Director | A | — | — |
| 2025-04-02 | David Moradi | CHIEF EXECUTIVE OFFICER | A | — | — |
| 2025-04-02 | Carr Bettis | EXEC CHRMN/CHRMN OF THE BOARD | MIXED | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | See Remarks | 3,273,488 | — |
| — | EXECUTIVE CHAIRMAN AND CPO | 2,752,908 | — |
| — | EXEC CHRMN/CHRMN OF THE BOARD | 654,671 | — |
| — | Director | 369,257 | — |
| — | Director | 337,295 | — |
| — | President and CSO | 250,885 | — |
| — | Director | 217,684 | — |
| — | Director | 195,261 | — |
| — | CEO, CFO AND SECRETARY | 170,620 | — |
| — | Director | 142,345 | — |
| — | Chief Financial Officer | 134,834 | — |
| — | Chief Executive Officer | 88,766 | — |
| — | Director | 84,340 | — |
| — | President | 76,166 | — |
| — | CHIEF OPERATING OFFICER | 70,022 | — |
| — | Director | 45,328 | — |
| — | Chief Executive Officer | 12,010 | — |
| — | Chief Financial Officer | 3,000 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the AEYE quote page; the site-wide leaderboard is on the insider transactions hub.